SEC EDGAR Filing Information

Form 10-K -- Annual report [Section 13 and 15(d), not S-K Item 405]

Period of Report: 2005-12-31
Filing Date Changed: 2006-03-15
Documents: 8

SEC Accession No.
0001193125-06-054876
Filing date: 2006-03-15
Accepted: 2006-03-15 14:56:44

Table of submitted documents:

Seq	Type	Document	Size	Description
1	10-K	d10k.htm	1523280	FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2005
2	EX-14	dex14.htm	78620	CODE OF ETHICS
3	EX-21	dex21.htm	13067	SUBSIDIARIES OF THE REGISTRANT
4	EX-31.1	dex311.htm	9449	SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
5	EX-31.2	dex312.htm	9496	SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER
6	EX-32.1	dex321.htm	3462	SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
7	EX-32.2	dex322.htm	3657	SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER
8	GRAPHIC	g51294image002.jpg	2726	GRAPHIC

		0001193125-06-054876.txt	1646366	Complete submission text file

Filer Information:

US ONCOLOGY INC (Filer) (0000943061)
IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26190 | Film No.: 06687901
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Assistant Director 1

Business Address
16825 NORTHCHASE DR
STE 1300
HOUSTON TX 77060
2818732674

Mailing Address